Constipation resident survival guide: Difference between revisions
No edit summary |
No edit summary |
||
Line 203: | Line 203: | ||
{{familytree | | | | | | | | E01 | | | | | | | | | | | | | |E01=<div style="float: left; text-align: left; width: 25em; padding:1em;">❑ Adjust or discontinue medications causing constipation<br> | {{familytree | | | | | | | | E01 | | | | | | | | | | | | | |E01=<div style="float: left; text-align: left; width: 25em; padding:1em;">❑ Adjust or discontinue medications causing constipation<br> | ||
---- | ---- | ||
❑ Administer a trial of fiber and/or laxatives<br> | ❑ Administer a trial of fiber and/or osmotic or stimulant laxatives<br> | ||
---- | ---- | ||
''' | '''If secondary causes of constipation are uncovered during evaluation:'''<br> | ||
Due to metabolic conditions, myopathies, neuropathies, or other conditions<br> | |||
❑ Treat the [[Constipation causes#Causes by Organ System|secondary cause]]<br> | |||
'''or''' | '''or'''<br> | ||
❑ Offer symptomatic treatment<br> | |||
---- | ---- | ||
''' | '''If organic causes of constipation are uncovered during evaluation:'''<br> | ||
Due to mechanical obstruction or adverse drug effect<br> | |||
❑ Treat mechanical obstruction or remove the drug causing constipation<br> | |||
'''or''' | '''or'''<br> | ||
❑ Offer symptomatic treatment<br> | |||
---- | ---- | ||
'''[[Irritable bowel syndrome history and symptoms#Diagnostic Criteria| | '''If [[Irritable bowel syndrome history and symptoms#Diagnostic Criteria|irritable bowel syndrome]] is diagnosed during evaluation:''' | ||
❑ | ❑ Treat [[Irritable bowel syndrome medical therapy|irritable bowel syndrome]]</div>}} | ||
{{familytree | | | | |,|-|-|-|^|-|-|-|.| | | | | | | | | | |}} | {{familytree | | | | |,|-|-|-|^|-|-|-|.| | | | | | | | | | |}} | ||
{{familytree | | | | F01 | | | | | | F02 | | | | | | | | | |F01=Adequate response to trial of fiber and/or laxatives|F02=Inadequate response to trial of fiber and/or laxatives}} | {{familytree | | | | F01 | | | | | | F02 | | | | | | | | | |F01=Adequate response to trial of fiber and/or laxatives|F02=Inadequate response to trial of fiber and/or laxatives}} | ||
Line 260: | Line 260: | ||
---- | ---- | ||
'''Add hyperosmolar agents:'''<br> | '''Add hyperosmolar agents:'''<br> | ||
❑ [[Polyethylene glycol]]: 8-32 oz | ❑ [[Polyethylene glycol]]: 8-32 oz OD | ||
:❑ 2 weeks to 24 months | :❑ 2 weeks to 24 months | ||
:❑ Polyethylene glycol with electrolyte containing preparation indicated when large volume is used for colonic cleansing <br> | :❑ Polyethylene glycol with electrolyte containing preparation indicated when large volume is used for colonic cleansing <br> | ||
Line 270: | Line 270: | ||
❑ [[Bisacodyl]] | ❑ [[Bisacodyl]] | ||
:❑ 10 mg suppositories<br> '''or''' <br> | :❑ 10 mg suppositories<br> '''or''' <br> | ||
:❑ 5-10 mg orally up to 3 times/week<br> '''or''' <br> | :❑ 5-10 mg orally up to 3 times/week<br> | ||
'''or''' <br> | |||
❑ [[Glycerin]]: Suppository OD <br> | ❑ [[Glycerin]]: Suppository OD <br> | ||
❑ [[Anthraquinones]] | ❑ [[Anthraquinones]] | ||
Line 287: | Line 288: | ||
{{familytree | | | | | A01 | | | | | | | | | | | | | | A01= '''Normal or slow transit constipation'''}} | {{familytree | | | | | A01 | | | | | | | | | | | | | | A01= '''Normal or slow transit constipation'''}} | ||
{{familytree | | | | | |!| | | | | | | | | | | | | | |}} | {{familytree | | | | | |!| | | | | | | | | | | | | | |}} | ||
{{familytree | | | | | B01 | | | | | | | | | | | | | | B01=<div style="float: left; text-align: left | {{familytree | | | | | B01 | | | | | | | | | | | | | | B01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Administer:'''<br> | ||
---- | ---- | ||
❑ [[ | ❑ Hyperosmolar agents | ||
❑ [[ | :❑ [[Polyethylene glycol]]: 8-32 oz OD<br> | ||
❑ [[ | '''or'''<br> | ||
❑ | ❑ Saline laxatives | ||
:❑ [[Milk of magnesia]]: 15-30 mL OD or BID<br> | |||
'''or'''<br> | |||
❑ Stimulant laxatives | |||
:❑ [[Bisacodyl]] | |||
::❑ 10 mg suppositories<br> '''or''' <br> | |||
::❑ 5-10 mg orally up to 3 times/week</div>}} | |||
{{familytree | | | |,|-|^|-|.| | | | | | | | | | | | | }} | |||
{{familytree | | | C01 | | C02 | | | | | | | | | | | | C01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Patient improves'''<br> | |||
---- | ---- | ||
''' | ❑ Continue the same regimen on a long term basis</div>|C02=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Patient does not improve'''<br> | ||
---- | ---- | ||
''' | ❑ Modify the treatment regimen by considering<br> | ||
:❑ Secretagogues | |||
::❑ Lubiprostone 24 μg BID <br> '''or''' <br> | |||
::❑ Linaclotide 145 μg daily<br> | |||
'''or'''<br> | |||
:❑ Serotonin 5-HT4 receptor agonists | |||
::❑ Prucalopridec</div>}} | |||
{{familytree | | | | | |,|-|^|-|.| | | | | | | | | | | }} | |||
{{familytree | | | | | D01 | | D02 | | | | | | | | | |D01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Patient improves'''<br> | |||
---- | ---- | ||
❑ | ❑ Continue the same regimen on a long term basis</div>|D02=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Patient does not improve'''<br> | ||
---- | ---- | ||
❑ | ❑ Repeat colonic transit test while continuing medications</div> }} | ||
{{familytree | | | | | | | |,|-|^|-|.| | | | | | | | | }} | |||
{{familytree | | | {{familytree | | | | | | | E01 | | E02 | | | | | | | E01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Delayed transit'''<br> | ||
{{familytree | | |||
---- | ---- | ||
❑ | ❑ Consider gastric emptying</div>|E02=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Normal transit'''<br> | ||
---- | ---- | ||
❑ | ❑ Adjust medications as needed</div>}} | ||
{{familytree | | | | |,|-|-|^|-|-|.| | | | | | | | | | }} | |||
{{familytree | | | | F01 | | | | F02 | | | | | | | | | |F01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Slow emptying'''<br> | |||
---- | ---- | ||
''' | ❑ Consider assessment for upper GI motility disorder</div>|F02='''Normal emptying''' }} | ||
{{familytree | | |,|-|^|-|.| | | |!| | | | | | | | | |}} | |||
{{familytree | | G01 | | G02 |-| G03 | | | | | | | |G01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Abnormal'''<br> | |||
---- | ---- | ||
''' | ❑ Manage the upper GI motility disorder appropriately</div>|G02='''Normal'''|G03=Consider colonic manometry ± barostat}} | ||
{{familytree | | | | | | | | |,|-|^|-|.| | | | | | | |}} | |||
{{familytree | | | | | | | | H01 | | H02 | | | | | | |H01=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Normal'''<br> | |||
---- | ---- | ||
❑ | ❑ Consider temporary loop ileostomy</div>|H02=<div style="float: left; text-align: left; width: 25em; padding:1em;">'''Abnormal'''<br> | ||
---- | ---- | ||
❑ Consider subtotal colectomy + ileorectal anastamosis</div>}} | |||
{{familytree/end}} | |||
===Defecatory disorder=== | |||
❑ | {{Family tree/start}} | ||
{{familytree | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | }} | ||
{{ | {{familytree | | | | | | | | A01 | | | | | | | | | | | | | | A01=<div style="float: left; text-align: left; width: 17em; padding:1em;">Chronic constipation who have not responded to a high-fiber diet and/or over-the-counter laxatives after organic disorders have been excluded </div>}} | ||
{{familytree | | | | {{familytree | | | | | | | | |!| | | | | | | | | | | | | | |}} | ||
{{familytree | | | {{familytree | | | | | | | | A01 | | | | | | | | | | | | | | A01=<div style="float: left; text-align: left; width: 17em; padding:1em;">'''Order specific tests:'''<br> | ||
{{familytree | | | | ------------ | ||
{{familytree | | | ❑ [[Constipation other imaging findings#Rectal Balloon Expulsion Test|Rectal Balloon Expulsion Test (BET)]] <br> | ||
---- | ❑ [[Constipation other imaging findings#Anorectal Function Tests|Anorectal Manometry (ARM)]]<br> | ||
❑ [[ | ❑ [[Constipation other imaging findings#Defecography|Barium, Scintigraphic, and Magnetic Resonance Defecography (BD)]] <br> | ||
❑ [[ | ❑ [[Constipation other imaging findings#Colorectal Transit Study|Colonic Transit Test (CTT)]] <br> </div>}} | ||
{{familytree | | | | | | | | | | {{familytree | | |,|-|-|-|v|-|^|-|v|-|-|-|.| | | | | | | | | | | |}} | ||
{{familytree | | A01 | | A02 | | A03 | | A04 | | | | | | | | A01= Normal BET, ARM, BD, CTT| A02=Abnormal CTT<br>Normal BET, ARM, BD |A03= Abnormal BET, ARM, BD <br> Normal CTT| A04= Abnormal BET, ARM, BD, CTT}} | |||
{{familytree | | |!| | | |!| | | |!| | | |!| | | | | | | |}} | |||
{{familytree | | A01 | | A02 | | A03 | | A04 | | | | | | | | A01=Normal transit constipation| A02=Slow transit constipation| A03=Pelvic floor dysfunction| A04= Combined slow transit constipation and pelvic floor dysfunction}} | |||
{{familytree | | | | | | | |||
{{familytree | | |! | |||
{{familytree | | | | | | |||
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | {{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Line 479: | Line 462: | ||
{{familytree | H01 | | | | | | |H01=Consider surgery if no improvement}} | {{familytree | H01 | | | | | | |H01=Consider surgery if no improvement}} | ||
{{familytree/end}} | {{familytree/end}} | ||
==Do's== | ==Do's== |
Revision as of 20:50, 18 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mugilan Poongkunran M.B.B.S [2]
Definition
Constipation is a syndrome that is characterized by difficulty in passing stool, by infrequent bowel movements, by hard stool, or by a feeling of incomplete evacuation that occurs either in isolation or secondary to another underlying disorder.[1][2][3]
Clinical subgroups | Definitions |
---|---|
Normal transit constipation | Normal transit constipation refers to constipation in patients with normal anorectal function and normal colonic transit, with or without abnormal colonic motor disturbances and abnormal (ie, reduced or increased) colonic sensations. |
Slow transit constipation | Slow transit constipation refers to constipation in patients with normal anorectal function but slow colonic transit, with or without abnormal colonic motor disturbances and abnormal (ie, reduced or increased) colonic sensations. |
Defecatory disorders (Outlet obstruction, obstructed defecation, dyschezia, anismus, or pelvic floor dyssynergia) |
Defecatory disorders refer to constipation in patients with impaired rectal evacuation from inadequate rectal propulsive forces and/or increased resistance to evacuation during defecation, with or without structural disturbances like rectocele and intussusception, reduced rectal sensation, and slow colonic transit. Increased resistance to evacuation might follow high anal resting pressure (anismus) and/or incomplete relaxation or paradoxical contraction of the pelvic floor and external anal sphincters (dyssynergia). |
Combination disorders | Combination disorders refer to patients with combination or overlap of disorders (eg, STC with defecatory disorders), perhaps even an association with features of irritable bowel syndrome. |
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.
- Atropine poisoning
- Hypokalemia
- Lead poisoning
- Opium poisoning
- Severe dehydration
- Spinal cord injury
- Superior mesenteric artery occlusion
Common Causes
- Hardening of the feces: Improper mastication, low dietary fiber, dehydration and medications (aluminium, calcium, diuretic, iron).
- Paralysis or slowed transit: Hypothyroidism, hypokalemia, injured anal sphincter, medications (loperamide, codeine, morphine, tricyclic antidepressants) and severe systemic illness due to other causes.
- Constriction, where part of the intestine or rectum is narrowed or blocked: Diverticulosis, pelvic masses and stenosis.
- Psychosomatic constipation: Functional constipation and irritable bowel syndrome.[4]
- Smoking cessation[5]
- Abdominal surgery and childbirth
Management
Diagnostic Approach
Shown below is an algorithm depicting the diagnostic approach of constipation in adults based on the American Gastroenterological Association (AGA) guideline.[1][6]
Characterize the symptoms: Symptoms suggestive of constipation: ❑ Difficulty in passing stool
❑ Infrequency in passing stool
❑ Use of enemas to pass stool Symptoms associated with constipation: ❑ Abdominal pain or abdominal discomfort:
❑ Abdominal distention Obtain a detailed history: ❑ Diet: ❑ Medications:
❑ Systemic illness:
❑ Surgical history:
❑ Trauma history: Spinal cord injury
❑ Personal history:
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Examine the patient: ❑ General examination: ❑ Perineal/rectal examination:
❑ Abdominal examination:
❑ Neurological examination:
❑ Cardiovascular examination:
❑ Respiratory examination
❑ Skeletal examination
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Order laboratory tests: ❑ CBC When secondary causes are suspected: Consider structural evaluation of the colon: | |||||||||||||||||||||||||||||||||||||||||||||||||||
Consider the diagnostic criteria of constipation Rome III criteria:[1][7] Symptoms for ≥6 months and ≥2 of the following for the past 3 months:
Pharmacologic studies based criteria:[1][8]
| |||||||||||||||||||||||||||||||||||||||||||||||||||
❑ Adjust or discontinue medications causing constipation ❑ Administer a trial of fiber and/or osmotic or stimulant laxatives If secondary causes of constipation are uncovered during evaluation: If organic causes of constipation are uncovered during evaluation: If irritable bowel syndrome is diagnosed during evaluation: ❑ Treat irritable bowel syndrome | |||||||||||||||||||||||||||||||||||||||||||||||||||
Adequate response to trial of fiber and/or laxatives | Inadequate response to trial of fiber and/or laxatives | ||||||||||||||||||||||||||||||||||||||||||||||||||
General management of constipation | ❑ Gastroenterology consult ❑ Anorectal manometry ❑ Balloon expulsion test | ||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Inconclusive | Abnormal | |||||||||||||||||||||||||||||||||||||||||||||||||
❑ Barium defecography or ❑ MR defecography | |||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Abnormal | ||||||||||||||||||||||||||||||||||||||||||||||||||
Colonic transit | Defecatory disorder | ||||||||||||||||||||||||||||||||||||||||||||||||||
Slow | Normal | ||||||||||||||||||||||||||||||||||||||||||||||||||
Slow transit constipation | Normal transit constipation | ||||||||||||||||||||||||||||||||||||||||||||||||||
Therapeutic Approach
Shown below are algorithms depicting the general as well as clinical subgroups based therapeutic approaches of constipation in adults based on the American Gastroenterological Association (AGA) guideline.[1][6]
General Management
Constipation | |||||||||||||||||||||||||||||||||||||||||||||||
Start treatment with dietary fiber supplementation: ❑ Psyllium: 1 tsp up to 3 times daily ❑ Advice to take along with fluids and/or meals ❑ Advice increased fluid intake if dehydration is present ❑ Advice on increasing physical activity | |||||||||||||||||||||||||||||||||||||||||||||||
If more treatment is needed: Add hyperosmolar agents:
or Supplement with stimulant laxatives as needed:
or
❑ Administer suppositories 30 minutes after breakfast If necessary administer: | |||||||||||||||||||||||||||||||||||||||||||||||
Normal and Slow Transit Constipation
Normal or slow transit constipation | |||||||||||||||||||||||||||||||||||||||||
Administer: ❑ Hyperosmolar agents
or
or
| |||||||||||||||||||||||||||||||||||||||||
Patient improves ❑ Continue the same regimen on a long term basis | Patient does not improve ❑ Modify the treatment regimen by considering
or
| ||||||||||||||||||||||||||||||||||||||||
Patient improves ❑ Continue the same regimen on a long term basis | Patient does not improve ❑ Repeat colonic transit test while continuing medications | ||||||||||||||||||||||||||||||||||||||||
Delayed transit ❑ Consider gastric emptying | Normal transit ❑ Adjust medications as needed | ||||||||||||||||||||||||||||||||||||||||
Slow emptying ❑ Consider assessment for upper GI motility disorder | Normal emptying | ||||||||||||||||||||||||||||||||||||||||
Abnormal ❑ Manage the upper GI motility disorder appropriately | Normal | Consider colonic manometry ± barostat | |||||||||||||||||||||||||||||||||||||||
Normal ❑ Consider temporary loop ileostomy | Abnormal ❑ Consider subtotal colectomy + ileorectal anastamosis | ||||||||||||||||||||||||||||||||||||||||
Defecatory disorder
Chronic constipation who have not responded to a high-fiber diet and/or over-the-counter laxatives after organic disorders have been excluded | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal BET, ARM, BD, CTT | Abnormal CTT Normal BET, ARM, BD | Abnormal BET, ARM, BD Normal CTT | Abnormal BET, ARM, BD, CTT | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal transit constipation | Slow transit constipation | Pelvic floor dysfunction | Combined slow transit constipation and pelvic floor dysfunction | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pelvic Floor Dysfunction
Pelvic floor dysfunction | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abnormal BET or BD ❑ Define rectoanal angle High resting pressure ❑ Rule out anal fissure first Abnormal reflex ❑ Absence of rectoanal inhibitory reflex | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fiber ❑ Psyllium: 1 tsp up to 3 times daily PLUS Stimulant laxative ❑ Bisacodyl: 10 mg suppositories or 5-10 mg orally up to 3 times/wk | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biofeedback ❑ Anorectal and pelvic floor muscle activity are recorded by surface electromyographic sensors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Follow clinically | Repeat balloon expulsion test | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abnormal | Normal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perform defecating proctogram | Manage as normal transit constipation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Abnormal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reassess biofeedback + medications if needed | Define anatomic rectal defect | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No response | Clinically significant | Insignificant | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider surgery | Surgical repair and follow up | No surgery needed | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Combined Pelvic Floor Dysfunction and Slow Transit Constipation
Combined pelvic floor dysfunction and slow transit constipation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Biofeedback PLUS Dietary fiber: Psyllium/methylcellulose PLUS Stimulant laxative: Bisacodyl PLUS Saline laxative: Milk of magnesia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Response to treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perform colonic transit test without medications | Repeat balloon expulsion test | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
If delayed manage as slow transit constipation | If normal follow clinically | Abnormal | Normal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Perform defecating proctogram | Manage as slow transit constipation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Abnormal | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reassess biofeedback + add hyperosmolar agents (lactulose/PEG) | Define anatomic rectal defect | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No improvement | No response | Clinically significant | Insignificant | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Repeat colonic transit test on medications | Continue therapeutic regimen | Surgical repair and follow up | No surgery needed | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Delayed | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjust medications as needed | Consider surgery | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Consider surgery if no improvement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Do begin evaluation of constipation with a detailed history and physical examination that includes a rectal examination.
- Do perform a colonoscopy in patient's presenting with the recent onset of constipation without an obvious explanation, hematochezia, weight loss of ≥10 pounds, a family history of colon cancer or inflammatory bowel disease, anemia and positive fecal occult blood test.
- Do perform a trial of conservative management of lifestyle and dietary modification in patients without any of the above alarm symptoms.
Dont's
- Dont use insoluble fiber like wheat bran for the intial managment of constipation in adults.
References
- ↑ 1.0 1.1 1.2 1.3 1.4 Bharucha AE, Pemberton JH, Locke GR (2013). "American Gastroenterological Association technical review on constipation". Gastroenterology. 144 (1): 218–38. doi:10.1053/j.gastro.2012.10.028. PMC 3531555. PMID 23261065.
- ↑ American College of Gastroenterology Chronic Constipation Task Force (2005). "An evidence-based approach to the management of chronic constipation in North America". Am J Gastroenterol. 100 Suppl 1: S1–4. doi:10.1111/j.1572-0241.2005.50613_1.x. PMID 16008640.
- ↑ Locke GR, Pemberton JH, Phillips SF (2000). "American Gastroenterological Association Medical Position Statement: guidelines on constipation". Gastroenterology. 119 (6): 1761–6. PMID 11113098.
- ↑ Caldarella MP, Milano A, Laterza F; et al. (2005). "Visceral sensitivity and symptoms in patients with constipation- or diarrhea-predominant irritable bowel syndrome (IBS): effect of a low-fat intraduodenal infusion". Am. J. Gastroenterol. 100 (2): 383–9. doi:10.1111/j.1572-0241.2005.40100.x. PMID 15667496.
- ↑ "Nicotine withdrawal symptoms:Constipation". helpwithsmoking.com. 2005. Retrieved 2007-06-29.
- ↑ 6.0 6.1 Bharucha, AE.; Dorn, SD.; Lembo, A.; Pressman, A. (2013). "American Gastroenterological Association medical position statement on constipation". Gastroenterology. 144 (1): 211–7. doi:10.1053/j.gastro.2012.10.029. PMID 23261064. Unknown parameter
|month=
ignored (help) - ↑ Longstreth, GF.; Thompson, WG.; Chey, WD.; Houghton, LA.; Mearin, F.; Spiller, RC. (2006). "Functional bowel disorders". Gastroenterology. 130 (5): 1480–91. doi:10.1053/j.gastro.2005.11.061. PMID 16678561. Unknown parameter
|month=
ignored (help) - ↑ Lembo, AJ.; Kurtz, CB.; Macdougall, JE.; Lavins, BJ.; Currie, MG.; Fitch, DA.; Jeglinski, BI.; Johnston, JM. (2010). "Efficacy of linaclotide for patients with chronic constipation". Gastroenterology. 138 (3): 886–95.e1. doi:10.1053/j.gastro.2009.12.050. PMID 20045700. Unknown parameter
|month=
ignored (help)